PosterSessionOnline

WORLD FEDERATION OF HEMOPHILIA

WFH 2024 World Congress

21 - 24 April 2024, Madrid

N. Poster

Poster title

Applicant name

Status


MP-001	F8 Mutation spectrum in a large cohort of Hemophilia A patients from an Italian Regional Reference Centre: an update	Federica Riccardi	Received

PP-001	Genetic etiology of a cohort of Uruguayan hemophilic patients and carriers	Yasser Vega	Received

PP-002	Molecular insights into the mechanism of large F9 deletions in three families with severe hemophilia B	Liliana Rossetti	Received

MP-002	KOHEM summer camp, recovery of Korea bleeding disorder community after the pandemic	Nam-il Lee	Received

LBAPP-002	Variant pHis118Arg in a patient with Severe Hemophilia A determines the presence of a mild phenotype	Gisela Barros Garcia	Received

PO-002	In silico evaluation of Danazol for bleeding disorders: The good, the bad and the ugly	Yara Maria Da Silva Pires	Received

MP-003	PACT - Bridging Hemophilia Care Gaps	Lubna Zafar	Received

PP-003	Unleashing the Power of Large Language Models Specific for Hemophilia Research	Tiago Lopes	Received

PO-003	My Opinion	Tania Maria Onzi Pietrobelli	Received

LBAPP-003	Replacement therapy outcomes in patients with haemophilia receiving antithrombotic therapy	Matteo Di Minno	Received

MP-004	Development of an online educational case-based tool to supplement hematology trainee understanding of hemostatic disorders and their management.	Kelsey Uminski	Received

PP-4	Detection of intron 1 and 22 inversions in the factor VIII gene by IS-PCR modified by capillary electrophoresis in patients and carriers of severe hemophilia A	Ana-Rebeca Jaloma-Cruz	Received

PO-4	Equality, its in our blood	Mark Ward	Received

LBAPP-004	Multicenter retrospective and prospective analysis of Emicizumab and FVIII prophylaxis in children with severe hemophilia A.	Tamer Hassan	Received

MP-005	Being a patient researcher for one day: an original proposition to celebrate the World Haemophilia Day	Thomas Sannié	Received

PO-5	Cocreating to improve patient experience in a pediatric hemophilia unit	Rubén Berrueco	Received

PP-005	Dominant negative effects of Gln50Arg mutation in the EGF-1 domain of factor IX causes severe Hemophilia B that negatively affects factor IX replacement therapy	Tirsa van Duijl	Received

LBAPP-005	Effectiveness of kinesiologic taping on function and pain in patients with Hemophilia A	Elif Güler Kazanci	Received

PO-006	Care Models In The Management Of Bleed Events In Persons With Hemophilia In Western Kenya	Nancy Midiwo	Received

PP-006	CATALYZING CARE: The Inauguration of Quetta Chapter under WFH-PACT	Masood Fareed Malik	Received

MP-006	Its Now: The Place of Youth in Hemophilia Spaces	Mateo Palladino Miserere	Received

MP-007	Driving an educational programme for teenagers living with haemophilia: importance of a partnership between AFH resource patients and healthcare professionals	Thomas Sannié	Received

PO-007	The development and expansion of the nurse-led genetic counselling service for female carriers	janet Cleary	Received

PP-007	Permanent Training Center in Hemophilia Hnos. Manuel and Javier Moreno	Javier Montoya Nicolas	Received

PP-008	Educational and informative materials for primary care health professionals, affected and families.	Javier Montoya Nicolas	Received

PO-008	Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment	Jiaan-Der Wang	Received

PO-009	Use of drugs in the management of Malagasy patients with hemophilia	Tamby Rakoto Alson Andrianjafiarinoa	Received

PP-009	Effectiveness of the National Bleeding Disorders Foundation support of state chapter advocacy programs	Nathan Schaefer	Received

MP-009	Building the future of advocacy: Uruguays inclusion of young leaders	Juan Andres Pereira de Souza	Received

PP-010	Formation of leaders in the Americas:results of the strategic alliance	Antonio Gomez Cavallini	Received

PO-010	Satisfaction survey for people with hemophilia (PWH)	Kaouther Zahra	Received

MP-010	Social media strategy as a key to success in NMO advocacy plans/campaigns: Uruguay best practice	Mathias Guerreiro	Received

PO-011	Assessment of access to factor VIII and factor IX to persons with Hemophilia during emergencies: a quality improvement study	Kara Burge	Received

PP-011	Hemophilia A Rapid card testing in outreach programs: Experience from a single tertiary care centre in Kerala	Bitty Kurian	Received

PP-012	A Pilot Study on the Effectiveness of the World Federation of Hemophilia (WFH) Shared Decision-Making (SDM) Tool	Donna Coffin	Received

PO-013	Three-year interim analysis results of AOZORA study	Midori Shima	Received

MP-013	Three years of achievements and challenges in care of people with moderate haemophilia: results from a nationwide registry	Sergio Cáceres	Received

PP-013	Assessment of Canadian standards of care	David Page	Received

PP-014	Introduction of an outpatient pathway for ankle arthrodesis surgery for people with severe haemophilia	Deirdre Gorman	Received

PO-014	Real-world data on treatment regimen and medical use among patients with hemophilia B in South Korea	Eun Jin Choi	Received

MP-14	Implementation of Home Therapy in Mauritius	Janaki Sonoo	Received

MP-015	Quality improvement initiative involving electronic health records to improve the safety of bleeding disorder patients in the emergency department	Nancy Hodgson	Received

PO-015	Efanesoctocog alfa treatment for children below 12 years of age with severe haemophilia A: A plain language summary of the XTEND-Kids study	Costello Medical	Received

PP-015	Emicizumab: Real world experience from a single center	Lubna Zafar	Received

PO-016	Safety, tolerability, pharmacokinetics and pharmacodynamics of Mim8 in patients with haemophilia A: FRONTIER1 extension	Pratima Chowdary	Received

MP-016	Low-dose Prophy and chemical synovectomy : A new concept of optimal prophylaxis to preserve joint health for severe hemophilic patients living in resource-limited countries.	Laurent Frenzel	Received

PP-016	Healthcare professionals view on the use-case scenarios for point-of-care testing in hemophilia A patients in a home-setting	Aernoud Bavinck	Received

PP-017	Overview of medical care and support for patients living with haemophilia in the Democratic Republic of Congo, Kinshasa in 2023	Jonathan Kukila	Received

PP-018	Progress in hemophilia care in the Democratic Republic of Congo from 2017 to today.	Gueth KUNDABI AKOTO Bill	Received

PO-18	A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People with Non-Neoplastic Hematologic Disorders	Tammuella Chrisentery-Singleton	Received

MP-018	Active lifestyle in patients with haemophilia A or B with and without inhibitors on once-daily subcutaneous concizumab prophylaxis: Results from the phase 3 explorer7 and explorer8 trials	Víctor Jiménez-Yuste	Received

MP-19	Prevalence of venous thromboembolism in people with inherited bleeding disorders: Real world data from the ATHNdataset	Shreya Agarwal	Received

PO-019	Clinical Profile and Cardiovascular Rrisk Factors among Hemophilians followed at University Clinics of Kinshasa	Gueth KUNDABI AKOTO Bill	Received

PP-020	Epidemiology of initial severe bleeding revealing a rare bleeding disorder: a francecoag network study	Sandrine Meunier	Received

MP-020	Biliary disorders among people with hemophilia: Findings from a case-control claims analysis	Steven Pipe	Received

PO-020	Direct Data Transfer of People with Hereditary Bleeding Disorders from the Hereditary Bleeding Disorder Registry in Thailand to the World Bleeding Disorders Registry and the Annual Global Survey of the World Federation of Hemophilia	Ampaiwan Chuansumrit	Received

PP-021	Summercamp for children with hemophilia in Murcia (2023)	Sara Caracena López	Received

PO-021	Improved quality of life in people with hemophilia A following gene therapy with dirloctocogene samoparvovec (SPK-8011)	Helen Miller	Received

MP-021	Global efforts in uniting all stakeholders, including regulatory agencies, in ensuring safety of hemophilia gene therapy patients: the World Federation of Hemophilia Gene Therapy Registry	Mayss Naccache	Received

MP-022	Haemophilia Gene therapy: a proposed structure, process and timeline for patient discussion for a truly informed decision	Enrico Ferri Grazzi	Received

PP-22	Real experience of prophylaxis with emicizumab in patients with congenital hemophilia A with and without FVIII inhibitors in the HCUVA	Ángela Heredia Cano	Received

PP-23	Evolution of patient profile in the last twenty years in the Summercamp La Charca	Angela Heredia Cano	Received

MP-23	Clinical efficacy of interventions for adult patients with moderately severe to severe hemophilia B: An indirect treatment comparison with fidanacogene elaparvovec	Valeria Merla	Received

PO-023	Bioethical aspects of gene therapy in patients with hemophilia	JORGE MARTIN CAMPOY	Received

MP-024	Value contribution of etranacogene dezaparvovec for the treatment of severe and moderately severe Haemophilia B in Spain through Multicriteria Decision Analysis (MCDA)	Daniel-Aníbal García Diego	Received

PO-24	Patients personal insights following a gene therapy clinical trial for hemophilia A	Christina Kirkegard	Received

PP-024	Real-world effectiveness and safety of damoctocog alfa pegol in patients with haemophilia A and a history of factor VIII inhibitors: a post-hoc analysis of the ongoing HEM-POWR study	María Teresa Álvarez-Román	Received

PP-025	Real-World Effectiveness of pegylated, recombinant Antihemophilic Factor (rurioctocog alfa pegol) Prophylaxis in Patients with Hemophilia A in Canada: A Retrospective, Intra-Patient Comparison with a Before-After Design	Arun Keepanasseril	Received

MP-025	Long-term evaluation of external quality assessment results for Factor VIII and Factor IX	Piet Meijer	Received

PO-25	ATHN Transcends Hemophilia Gene Therapy Outcomes Arm: A Long-Term Follow-Up Study on Safety and Effectiveness of Gene Therapy on People with Hemophilia	Tammuella Chrisentery-Singleton	Received

PO-026	Point-of-care Musculoskeletal Ultrasound Utilization and Outcomes in a Hemophilia Treatment Center	Curtis Yee	Received

MP-026	Performance control of eleven aPTT reagents for the quantification of an extended half-life factor IX	Pablo Martinez	Received

PP-026	Self-reflections, lessons learned, and suggestions for data quality assurance from a retrospective data analysis from the Canadian Bleeding Disorders Registry.	Arun Keepanasseril	Received

PO-027	Acquired hemophilia and human immunodeficiency virus: Case reports	Carole Kilach	Received

PP-27	The disruptive impact of extensive adoption of emicizumab on the clinical validation of new therapeutic agents in hemophilia A	Cedric Hermans	Received

MP-027	The use of different collagen binding assays aids in the diagnosis of von Willebrand disease	Fiona Shepherd	Received

PP-028	Management of Persons with Inherited Hemophilia Requiring Antithrombotic Therapy: A Canadian Modified Delphi Study.	Kelsey Uminski	Received

MP-028	Dose escalation of the anti-tissue factor pathway inhibitor marstacimab in participants with severe hemophilia without inhibitors: results from the phase 3 BASIS and long-term extension trials	Andrew Palladino	Received

PO-028	Management of life-threatening bleeding in a hemophilia B patient with high responder inhibitors: A case report	Te-Fu Weng	Received

PP-029	Application of self-monitoring smart devices to improve the health status in hemophiliacs	Soyon Kim	Received

MP-029	Efanesoctocog alfa treatment outcomes in subjects =50 years of age from the XTEND-1 trial	Hannah Nelson	Received

PP-030	Non-invasive evaluation of arterial stiffness and characterization of cardiovascular risk factors in a patients with hemophilia cohort in Uruguay	Joaquín Ferreira	Received

MP-30	Reduced recovery of turoctocog alfa pegol is not always associated with antidrug antibodies against polyethylene glycol: data from three patients	Gianna Franca Rivolta	Received

PP-031	Bleeding patterns and clotting factor concentrates utilisation in haemophilia patients treated at Kamuzu Central Hospital, Malawi	Francis Mkwenembera	Received

MP-031	Evaluation of access to Care for Women/Carriers of Hemophilia in Hemophilia Treatment Centres: A Multinational Experience	Marlène Beijlevelt	Received

MP-032	Teaching health care staff about hemophilia: four educational resources to learn about bleeding disorders	Shamshah Aratia	Received

PO-032	F8 gene synonymous variants and their clinical correlation: our experience at La Paz University Hospital	Mikel Fernandez Artazcoz	Received

PO-033	Emicizumab prophylaxis: a single center clinical experience	Cristina Santoro	Received

PP-033	Clinicohematological profile of hemophilia patients at a tertiary care center in Eastern India	Ruchi Sinha	Received

MP-033	Intramuscular vs subcutaneous vaccination in children with haemophilia. Has the evidence changed since COVID19?	Charlotte Beeton	Received

PP-034	Enrollment of Malagasy Patients with Hemophilia in the World Bleeding Disorders Registry	Tendry Isaia Rakoto ANDRIANJAFIARINOA	Received

PO-034	Protein Design and Deep Learning: A New Frontier in Hemophilia B Management	Arthur Pimenta	Received

MP-034	Bridging the Practice Gaps in Hemophilia: Usability Study of HemoCopilot a Comprehensive Digital Self-assessment Solution	Emilie Guilpain	Received

PP-35	Case Series: Acquired hemophilia in Colombian patients	Sandro Parra Soto	Received

PO-035	Effect of intra-articular application of Platelet Rich Plasma-Ozonated in chronic hemophilic arthropathy.	Armando Raúl Hernández Salgado	Received

MP-035	Towards Tailoring the use of emicizumab for Hemophilia A children in China: a retrospective clinical data from a comprehensive care center of China	Qianqian Mao	Received

MP-036	Children with bleeding disorders who developed excess weight gain during the COVID-19 pandemic revert to their pre-pandemic weight and BMI percentiles a prospective follow-up of 76 children	Teodora Markovic	Received

PO-036	Effectiveness and safety of prophylaxis with emicizumab in Cuban patients with hemophilia A followed for two years	Dunia Castillo González	Received

PP-037	Socio-economic determinants and their impact on patients and families living with Hemophilia in a low- and middle-income country: An experience from a tertiary care center in Northern India	Pragya Kafley	Received

PO-037	Furniture and ludic elements design: musculoskeletal training for individuals with coagulopathies	Luis Porras	Received

MP-038	Hemotrack: Musculoskeletal Management in Hemophilia with Physiotherapist-Driven Digital Solutions	Sofía Pérez-Alenda	Received

PP-038	Exploring the Relationship between Economic Development and Underreported Bleeding Disorders	Richard Kelly	Received

MP-039	Preliminary results of OPG/RANKL levels in Haemophilia A patients (PWHA) on Emicizumab	Styliani-Despoina Christidi	Received

PO-040	Advanced practice registered nurses in coagulopathies in Spain: does it exist without a legal framework?	Sara García Barcenilla	Received

MP-040	Joint health outcomes in severe haemophilia A patients on primary prophylaxis and the influence of early bleeding phenotype and treatment	Alexandros Arvanitakis	Received

PP-040	Sociodemographic profile and socioeconomic level of patients at the Monterrey hemophilia care center, an inside look at the families	Laura Páez	Received

MP-041	Gender Differences in Parenting Stress and Social Support Among Hemophilia Families	Carletha Gates	Received

PO-041	Burden on parents of children with von Willebrand disease	Linda Myrin Westesson	Received

PO-042	Nurses perception of their work environment in Hemophilia and Congenital Coagulopathies Units.	Nuria Caballero	Received

MP-042	Qualitative research to the experience and needs surrounding pregnancy and childbirth in women with von Willebrand disease	Corinne Liem	Received

PP-042	Exploring Varied Clinical Profiles in Mild Hemophilia: Insights from the Castilla-La Mancha, Spain Hemophilia Registry	Sonia Herrero Martín	Received

MP-043	The Effects of Counseling using CBT(Cognitive-Behavioral-Therapy) on reducing irrational belief and interpersonal anxiety of Hemophilic Arthritis Patients - Comparative Study of Individual Counseling and Group Counseling=	WONSOOK BAK	Received

PP-043	Five-year analysis of laboratory services in hemostasis from a resource-limited setting: Experience from a single tertiary care center in Kerala, Southern India	Bitty Kurian	Received

PP-44	Exploring the clinical spectrum of factor VII deficiency in India: a retrospective study	Gohul Jalajakumari	Received

MP-044	Mental Health and Quality of Life in Children and Adolescents Living with Hemophilia, a Single Center Study in Pakistani Sample	Tahira Zafar	Received

PO-044	Nurse role and systematic collection of information in the visit to the patient with hemophilia.	Diego José Ramos Galindo	Received

PO-045	Nursing role as coordinator in a multidisciplinary team in patients with congenital coagulopathy during elective surgeries	Gemma Guillen Peramos	Received

MP-045	Training and coexistence days for children with coagulopathies in Spain	Daniel-Aníbal García Diego	Received

PP-045	Evolution of hemophilia care: analyzing factor VIII usage trends and the impact of novel therapies	Ellia Tootoonchian	Received

MP-046	Strengthening our life skills HAVI	David Cuartas	Received

PO-046	Nurse role in clinical trials of patients with congenital coagulation disorders	Diego José Ramos Galindo	Received

PP-046	Factors associated with delayed diagnostic of inherited bleeding disorders in LMIC.	Saliou Diop	Received

PP-047	Population Pharmacokinetics in Hemophilia: Availability and Implementation in Latin-America. Results of the CLAHT-WFH Survey.	Jesus Ardila Novoa	Received

PO-047	Manage emotions to improve adaptation to haemophilia	Alfonso Castro-Blanco	Received

MP-047	Sexual Dysfunction and Anxiety in Women With Hereditary Bleeding Disorders	Basak Koc	Received

PO-048	The role of nursing in hemophilia camps	Alfonso Castro-Blanco	Received

MP-048	Depression among patients with hemophilia	Ana Paola Abreu Bastar	Received

PP-049	Factor VIII in Female Patients with Hemophilia A (PwH): A Laboratory Analysis.	Gloria Ramos Ramos	Received

PO-049	Learning to self-administer treatment through play	M Carmen García-Rivera	Received

MP-049	Health-Related Quality of Life in People with Hemophilia in Italy: a Single-Center Cross-Sectional survey	Angelo Claudio Molinari	Received

PP-050	Gene Therapy Education Program - A CHS comprehensive information program	Chantal Raymond	Received

MP-050	Mental health outcomes from the Learning to Live with Non-severe Haemophilia study: Combining coreHEM Mental Health Outlook and qualitative interviews	Simon Fletcher	Received

PO-051	Health Improvement in an Adolescent with Type A Hemophilia using Emicizumab	Camila Stephanes	Received

MP-051	Health-Related Quality of Life and Chronic Pain Burden on a Cohort of People with Haemophilia in 5 European Countries: an Updated Snapshot from the Cost of Haemophilia in Europe: a Longitudinal Socio-Economic Survey (CHESS)	Enrico Ferri Grazzi	Received

PP-051	Gene Therapy for Hemophilia Clearing House: a single repository of resources for hemophilia	Taryn Bosquez-Berger	Received

PP-052	The World Federation of Hemophilia Living Guidelines Model	Mona Mayla	Received

MP-052	WiSH-QoL Study Health-Related Quality of Life (HRQoL) in adults with von Willebrand Disease (VWD) in France: Women cohort results	Marie-Hélène ANDRE-BONNET	Received

PO-52	Prevention through minimal invasion	Maria Mercedes Alba Bensich	Received

PP-053	A conceptual roadmap to an optimal Model of Care for effective and efficient gene therapy delivery in the UK: a multi-disciplinary multi-stakeholder approach	Enrico Ferri Grazzi	Received

PO-053	Management and Complete Oral Rehabilitation Under General Anaesthesia Including Extraction in a Patient with Suspected Factor I and Factor VIII Deficiencies: A Case Report	Abdulmajeed Alrumi	Received

MP-53	The needs of people living with extremely rare bleeding disorders and bleeding disorders of unknown cause	Maja Johanne Sndergaard Knudsen	Received

MP-054	A unique case of recurrent venous thromboembolism in severe factor XIII deficiency	Lize van Vulpen	Received

PO-054	Heterotopic Ossification in Bleeding Disorders: A Multicenter Case Series	Bruno Steiner	Received

PP-054	Long-term retention plan through myGTR a patient engagement tool from World Federation of Hemophilia Gene Therapy Registry	Toong Youttananukorn	Received

PP-055	Question and answer guide on gene therapy in hemophilia	Lourdes Pérez	Received

MP-055	Therapeutic elbow arthroscopy for advanced haemophilic arthropathy - A haemophilia tertiary centre experience	Rory Hammond	Received

MP-056	Comparing DDAVP response classifications in 149 children with von Willebrand disease	Michael Shu	Received

PP-056	A multi-stakeholder, collaborative approach to awareness, education and support needed in the haemophilia gene therapy patient journey: insights from a patient advisory board	Karen Pinachyan	Received

PO-056	Platelet-Rich Plasma for chronic synovitis treatment, clinical outcomes over the years	María Landro	Received

MP-057	Evaluation of bleeding score in haemophilia carriers	Gabriela Sliba	Received

PP-057	Cost of factor concentrates for low dose prophylaxis in severe phenotype hemophilia A under National Health Security Office schemes in Thailand	Bunchoo Pongtanakul	Received

PO-057	Joint disease profile of cameroonian haemophiliac	Annick Ndoumba Nkengue	Received

PP-058	Comparative Cross-Sectional Study on BMI in Children Aged 8 to 12 Years with Hemophilia	JORGE MARTIN CAMPOY	Received

MP-058	Development of two unmet needs assessment tools for young women with a bleeding disorder and heavy menstrual bleeding	Jaime Chase	Received

PO-058	Destructive arthropathy due to hemarthrosis in a patient with Glanzmann thrombasthenia. case report	Mohamed Sharif	Received

PO-059	Treatment of hemophilic pseudotumor, with and without high-response inhibitor, report of two cases.	Armando Raúl Hernández Salgado	Received

PP-059	Role of a NMO in the P&R process	Miguel Ángel MARTÍN DOMINGUEZ	Received

MP-060	Hemophilia carriers in Tunisia: Where are we?	EYA DRISSI	Received

PO-060	Safety of radiosynovectomy with Yttrium-90 and Samarium-153 in patients with haemophilia	Rodrigo Pagnano	Received

PO-61	Patient Related Outcome Measures in Indian Hemophiliac PATIENTS after Elective Arthroplasty	Apeksha Kumar	Received

PP-061	The importance of Ultrasound as an objetive method for treatment modification	Mauro Davoli	Received

MP-061	Factor VIII Level in Mothers of Patients with Severe Hemophilia A and its Impact on Bleeding and Joint Status	Azza Tantawy	Received

MP-062	Needs of women and girls with coagulopathies in Spain	Lourdes Pérez	Received

PP-062	Critical role of Ultrasonography in hemophilia patients in developing countries: Revealing the inconspicuous.	Manali Bafna	Received

PO-062	Effect of a Physiotherapy Exercise Program on Quality Of Life and Pain in Iranian Patients With Severe Hemophilia	Vida Marzban	Received

MP-63	Use of recombinant von Willebrand factor concentrate for peri-partum haemostatic management of women with type 2 VWD; a case series	Daniel Daniel	Received

MPE-064	Incidence rates of arterial and venous thrombosis among people with hemophilia A or B	Guy Young	Received

PO-064	Exercise and physical conditioning in hemophilia: guidance booklets	Diogo Dias	Received

PP-064	Acquired hemophilia in the postpartum period: experience from two Italian hemophilia centres.	Gianluca Sottilotta	Received

PP-65	Prediction of inhibitor risk in Hemophilia A using Machine Learning	Tiago Lopes	Received

PO-065	Joint health and treatment received in a group of patients with hemophilia A from the National Hemophilia Center Venezuela 2023	Laura Aponte	Received

MPE-065	Adults with haemophilia B and history of chronic HCV/HBV infection receiving etranacogene dezaparvovec gene therapy in the HOPE-B clinical trial demonstrate long-term bleeding protection and sustained FIX Activity 3 years after administration	Claire Crouchley	Received

PP-066	severe inherited hemophilia A with inhibitors combined with a platelet function disorder case from Kuwait	Hadeel Mohammad	Received

MPE-066	Improved Joint Health After Gene Therapy with Dirloctocogene Samoparvovec (SPK-8011) in People with Hemophilia A	Kristen Jaworski	Received

PP-067	Type 3 von Willebrand disease with inhibitors (VWD3i) hemostatic control and transfusional complications.	Catarina Camara	Received

MPE-067	A novel gene editing lexicon strategy for the haemophilia community	Emily Tang	Received

PO-067	The value of home visits during a Twinning visit	Lize van Vulpen	Received

MPE-068	HIV comorbid Infection and etranacogene dezaparvovec therapy: efficacy and safety results from phase 2b and pivotal phase 3 HOPE-B trials 3 years after Administration	Claire Crouchley	Received

PP-068	FVIII post infusion monitoring Survey: Results & analysis of Extended half-life (EHL) FVIII/FIX products and laboratory performance for the external quality control assessment programmes of International External Quality Assessment Scheme (IEQAS)	Anna Williams	Received

PO-068	Escalating low-dose individualized haemophilia prophylaxis: A focus in China at Dawn of a new era of cost effective Individualized prophylaxis	Wanru Yao	Received

PP-069	FVIII post infusion monitoring global study: Results & analysis of newer and extended half-life (EHL) FVIII products across external quality assessment programmes of ECAT, UK NEQAS BC & RCPAQAP.	Anna Williams	Received

PO-069	Emicizumab prophylaxis: A novel alternative therapy for severe hemophilia A patients with and without inhibitors	Munira Borhany	Received

MPE-69	Epidemiological Insights into Hepatitis C Virus Infection among Patients with Inherited Bleeding Disorders: A 30-Year Evolution in a Brazilian Cohort	Nivia Foschi	Received

PP-070	Genetic mutation of haemophilia in Singapore in relation to its severity and inhibitor	SL Tien	Received

MPE-071	Multicenter evaluation of the haemostatic activity of emicizumab in patients with severe haemophilia A	Laurie Josset	Received

PO-071	Paradigm shift for haemophilia prophylactic treatment in a uruguayan adult haemophilia treatment centre	Maximiliano Berro	Received

PP-071	Platelet analysis by flow cytometry: EDTA or citrate sample?	Nour Mziou	Received

PO-72	Low Dose Prophylaxis in Haemophilia Using Extended Half- Life Factor Concentrates	Tahira Zafar	Received

MPE-072	PRO management and collection outside clinical research: why is it so difficult?	Laura González-Rodríguez	Received

PP-72	Global comparative antithrombin (AT) field study: Impact of laboratory assay variability on the assessment of AT activity measurement	Ekta Chhabra	Received

PP-073	Long-term performance of Factor VIII and Factor IX testing by laboratories of the Italian Hemophilia Centers	Piet Meijer	Received

PO-73	Real world experience with use of Emicizumab in haemophilia A patients: Case series report from Malawi	Francis Mkwenembera	Received

MPE-073	Functional and radiographic assessment in haemophilic arthropathy: is there a dissociation?	Rodrigo Pagnano	Received

PP-74	Factor IX activity measurement of recombinant FIX Fc fusion protein eftrenonacog alfa with one-stage clotting and chromogenic substrate assay	Marie Prudkova	Received

PO-074	Control of haemophilia treatment with extended half-life factors in Rosario, Argentina	Mariana Raviola	Received

MPE-074	Effects of resistance training on muscle strength in adults with haemophilia: a systematic review and meta-analysis	Rodrigo Núñez-Cortés	Received

PP-075	Comparisons of serum osteoprotegerin (OPG) and RANKL in Children, Adolescents and Adult patients with hemophilia: are there any differences?	AIKATERINI MICHALOPOULOU	Received

PO-075	The association between factor VIII pharmacokinetic parameters and clinical outcomes: design of the MoHem 2 study	Darwin Health Communications	Received

MPE-075	Enhancing hemophilia assessment and monitoring with novel digital biomarkers	Sébastien Lobet	Received

MPE-076	Generation of a viable mouse model of factor V deficiency: a mild disease phenotype	Andrea Miguel Batuecas	Received

PP-76	Real world variability in drug concentration during emicizumab therapy.	Susan Guy	Received

PO-076	Relationship between adherence and pain in patients on Emicizumab. Experience of a center in Rosario, Argentina.	Mariela Pasquero	Received

PO-077	Educational program for haemophilia in Gabon: development of prophylaxis for patients living with haemophilia.	Stan Marc Koumba Mihindou	Received

PP-077	Pitfalls encountered during inhibitor testing in travelled samples from peripheral camps	Savitri Singh	Received

MPE-077	HMB-001: A Phase 1/2, First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy in Participants with Glanzmann Thrombasthenia	Jigar Amin	Received

PO-078	Initial experience with Emicizumab prophylaxis in adults with severe Haemophilia A in a Uruguayan haemophilia treatment centre	Maximiliano Berro	Received

PP-78	Discrepancies in laboratory assays for extended half-life factor VIII/Factor IX products monitoring: experience from a single pediatric center in Argentina	Rodolfo Sueldo	Received

PP-79	Cut off for aFVIII inhibitor screening test	Rodolfo Sueldo	Received

PO-079	Challenges and burdens of long-lasting intravenous prophylaxis in adult haemophilia patients: a study from one centre	Jelena Bodrozic	Received

PP-080	A substudy to evaluate the feasibility and effectiveness of marstacimab administration using a prefilled pen injection device	Andrew Palladino	Received

PO-080	Conversation circle with patients taking emicizumab: an experience report	Alice Oliver Sacramento	Received

PO-081	Engaging with the great outdoors - a pilot project	Claire Forde	Received

PP-081	ENHANCING HEMOPHILIA CARE: Experiences with Emicizumab via World Federation of Hemophilias Humanitarian Aid Program	Masood Fareed Malik	Received

PO-082	CompartilHEMOS Experiences: Psychology Meeting of Psychologists from reference teams in the care of people with hemophilia in Brazil	Diogo Dias	Received

PP-082	Prophylaxis with emicizumab in 50 children and adolescents with severe hemophilia A without inhibitor in Uruguay. National experience.	Felipe Lemos	Received

PP-084	Breaking Barriers in Hemophilia A Care: One-Year Real-World Experience with Emicizumab Prophylaxis at Civil Service Hospital, Kathmandu, Nepal	bishesh sharma poudyal	Received

PP-085	Western States Regional Hemophilia Network (WSRHN) nursing tele-mentoring program	Mary Lesh	Received

PO-085	WFH-HUMANITARIAN AID: Enhancing the Quality of Life for Persons with Bleeding Disorders in Pakistan	Shahla T Sohail	Received

PO-086	Burden of disease and impact on quality of life in hereditary factor X deficiency patients who have experienced menorrhagia	Kim Clark	Received

PP-086	Haemophilia Nurse Consultant Role in adult haemophilia treatment centre in South Australia a 12 month analysis.	Yu-hsuan LIN	Received

PO-087	Burden of disease and impact on quality of life in hereditary factor X deficiency patients receiving prophylaxis	Kim Clark	Received

PP-087	Changes in the life of people with hemophilia A using emicizumab: nursing perceptions	Sonia Ferreira	Received

PP-088	Strategies to Promote Autonomy in Children, Adolescents, and Families Treated with Emicizumab	Florencia Gomez	Received

PO-089	Health-related quality-of-life, treatment burden and preference in patients with haemophilia: Results from the concizumab phase 3 explorer7 & 8 studies	Gary Benson	Received

PO-090	Living with Hemophilia in Latin America: An Evaluation of Youth Development Interventions to Improve Quality of Life	Deniece Chevannes	Received

PP-090	The use of Peripherally Inserted Central Catheter (PICC) Line for people with Haemophilia and other bleeding disorders:a single centre experience	Elsa Aradom	Received

PO-091	Quality of Life in Korean Hemophilia Patients: A Systematic Review	chang jihun	Received

PP-091	Cinical oral conditions in pediatric patients with inherited bleeding disorders in relation to hemorrhagic phenotype	Laura Beatriz Isidro Olán	Received

PP-092	Clinical features of hemophilic arthropathy of the elbow that progresses to irreversible lesions during childhood	Atsuki Yamashita	Received

PO-092	Treatment-related clinical and humanistic unmet needs in haemophilia A without inhibitors	Amy Shapiro	Received

PP-093	Low bone mineral density and vitamin D deficiency in patients with hemophilia in Taiwan	Tsung-Ying Li	Received

PO-093	SEEK Sharing Experience, Expanding Knowledge: A digital platform for patient-driven research in bleeding disorders	Luke Pembroke	Received

PP-094	World Federation of Hemophilia aid in orthopaedic surgeries: translational outcomes and real-world data from a single tertiary hemophilia care centre in India	Sandeep Abhijit Pattnaik	Received

PO-094	Evaluation of health-related quality of life in adolescents and adults with hemophilia treated in a rehabilitation unit.	Aideé Conde	Received

PO-095	Evaluation of Quality of Life in Patients with Von Willebrand Disease in a Health Institution in Colombia	Juan David Wilches Gutierrez	Received

PP-096	The frequency of bleeding in pediatric patients with moderate and mild hemophilia A and B- Polish experience	Pawel Laguna	Received

PO-096	Hemophilia and physical activity: impact of sport on the quality of life of people with Hemophilia	Carlos Pemán Asín	Received

PO-097	Addressing Iron Deficiency Anemia in Bleeding disorder patients: Lessons from a Single Center Perspective	Munira Borhany	Received

PP-097	Clinical and laboratory characteristics of children with platelet function disorders seen at a paediatric centre	Joyce Lam	Received

PP-098	Spectrum of Genetic Mutations in Haemophilia A and B Patients at a Paediatric Haemophilia Treatment Centre in Singapore	Chiew Ying Lim	Received

PO-098	Health-Related Quality of Life among Children and Adolescent Patients with Hemophilia: a Study in Argentinian Population	Maria Arrieta	Received

PO-099	Comparative study on health-related quality of life in children and adolescents with hemophilia in Argentina	Maria Elizabeth Arrieta	Received

PP-99	A survey of the experiences of parents of children with severe haemophilia, recently commenced on Hemlibra	Beatrice Nolan	Received

PO-100	Diagnosing and treating Bleeding Disorder of Unknown Cause (BDUC): an illustrated review on current practice and future directions (BDUC-iN study group and SYMPHONY consortium)	Amaury Monard	Received

PO-101	Long term reductions in haemarthrosis in Boys with severe haemophilia A: results of a three years follow up study on the China haemophilia secondary individualized prophylaxis study (CHIPS)	Wanru Yao	Received

PP-101	Factors related to quality of life in children with hemophilia A: a study in West Java, Indonesia	Sindy Febrianti	Received

PO-102	Glanzmann Thrombasthenia: identification of two novel mutations in Tunisia	gouider emna	Received

PP-102	Characteristics and Functional Impairment Level of Persons with Hemophilia with Peripheral Nerve Injuries	Easmin Doly	Received

PO-103	Evaluation of thromboelastometry, thrombin generation assay and bleeding score in patients with hereditary factor VII and factor XI deficiency	Petr Smejkal	Received

PP-103	Multidisciplinary survey of hemophilia treatment in Latin America: results from 17 reference centers	Carla Daffunchio	Received

PP-104	Physiotherapy in patients with hemophilia with virtual reality device	Cecilia Gallardo Pérez	Received

PO-105	Management of acquired hemophilia A cases using emicizumab and immunosuppressive therapy: A case-series	Varun Bafna	Received

PP-105	The Impact of dynapenia on handgrip force control in people with haemophilia	Rodrigo Núñez-Cortés	Received

PO-106	Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficiency Patients with Intravenous Plasminogen Replacement Therapy	Amy D. Shapiro	Received

PP-106	Gross motor development in infants with haemophilia. Comparisons with full-term and preterm infants of the same nationality	Dimitrios Syrengelas	Received

PO-107	An overview of Glanzmann Thrombasthenia in Portugal	Sara Morais	Received

PP-107	Haemophilia Physiotherapy A Challenge For Physiotherapist - A Real Time Experience From A Developing Country HTC	Dinkar Viswam	Received

PP-108	Assesment with Biopsychosocial Approach in Patients with Hereditary Bleeding Disorder	Tuge Poyraz Isleyen	Received

PO-109	Glanzmanns thrombasthenia and meningioma: a neurosurgical journey	Filipa Pires	Received

PP-109	Creating a work choice booklet: A Physical Therapist Collaboration	Jennifer Newman	Received

PP-110	Creating a sustainable network of physical therapists: Hemophilia Treatment Center Physical Therapy Collaborative.	Jennifer Newman	Received

PO-110	ATHN Transcends: Natural History Cohort Study of Bleeding Symptoms and Treatment Outcomes in Patients with Glanzmann Thrombasthenia	Tammuella Singleton	Received

PO-111	Surgical outcomes for people living with hemophilia in a resource constrained setting	Carole Kilach	Received

PP-112	Patients satisfaction on Rehabilitation Program (RP) in Kuressaare Hospital, Estonia	Martin Kaal	Received

PO-113	WFH Humanitarian Aid Program: Expanded Support for Hemophilia Care in Enugu, Nigeria	Theresa Nwagha	Received

PP-114	Monitoring people with hemophilia on low dose prophylaxis with Hemophilia joint health score	Emna Gouider	Received

PO-114	Development of a Comprehensive Questionnaire to Assess Disease Awareness in People with Hemophilia	Mariela Pasquero	Received

PP-115	Gene therapy for hemophilia: musculoskeletal transformations, patient experiences, and physiotherapist perspectives	JANAINA RICCIARDI	Received

PO-115	Paediatric population with moderate or severe von Willebrand disease in Sweden	Linda Myrin Westesson	Received

PP-116	Determination of cardiovascular risk in adult patients with hemophilia using the Framingham risk score and the artherosclerotic cardiovascular disease score	Aideé Gibraltar	Received

PO-116	Digital therapeutic education program for people concerned by Von Willebrand disease	Nicolas GUERIN	Received

PO-117	Management of patients with monoclonal gammopathy of undetermined significance and acquired von Willebrand disease	Gianluca Sottilotta	Received

PP-117	Impact of physical exercise in persons with congenital coagulopathies: Hemovement Project	JOSE MANUEL CALVO VILLAS	Received

PO-118	Real-world efficacy and safety of plasma-derived von Willebrand factor-containing FVIII concentrates in patients with Von Willebrand Disease in Italy: the RECLASFAWILL study	Augusto B Federici	Received

PP-118	Validation of a systematic review to evaluate the measurement properties of performance-based outcomes for the functional assessment of people with haemophilia	Catherine Holdsworth	Received

PP-119	Evaluation of Balance and Proprioception in adult and paediatric haemophilia patients	Daniel Zaldumbide	Received

PO-119	Safety and efficacy of the use of Fanhdi in patients with von Willebrand disease: a prospective, observational, post-authorization study	Alejhandra Lei	Received

PP-120	Lung function in adult hemophilia	Daniel Zaldumbide	Received

PO-120	Clinical, biochemical, and molecular characterization of Mexican patients with von Willebrand disease	Ana Jaloma	Received

PO-121	Long-term monitoring and multidisciplinary management of abnormal uterine bleeding in teenagers with type 3 von Willebrand disease	Novie Amelia Chozie	Received

PP-121	Joint manipulation and sliding in patients with severe hemophilia and ankle arthropathy. A controlled pilot study	Rubén Cuesta-Barriuso	Received

PP-122	Conditioned pain modulation in patients with hemophilic arthropathy. A cross-sectional cohort study.	Roberto Ucero-Lozano	Received

PO-122	Trauma and Taboo. Family story of WBD in 20th century Poland.	Bernadetta Pieczynska	Received

PO-123	Phenotype assessment and genetic study to the detection of Haemophilia B carriers.	Maria Veronica Arrieta	Received

PP-123	Safety and efficacy of blood flow restriction in patients with hemophilic knee arthropathy. A randomized pilot study.	Elena Donoso-Úbeda	Received

PP-124	Dependence of adult patients with haemophilia on instrumental activities of daily living. A cross-sectional cohort study	Rubén Cuesta-Barriuso	Received

PO-124	A case series of girls with hemophilia A	Fitri Primacakti	Received

PP-125	The Characteristics and Treatment Patterns in Hemophilia B Patients Receiving Recombinant Coagulation Factor IX	Sang Kyu Park	Received

PO-125	Hemophilia B Patient Journey	Tania Maria Onzi Pietrobelli	Received

PP-126	Racing against the odds: Comparing two types of prophylaxis in the context of Hemophilia A and marathon running	Michelle Bech	Received

PP-127	Comparison of spontaneous bleeding incidents despite use of prophylactic factor treatments in the era of Emicizumab use over 12 months for patients with Moderate or severe Haemophilia A in an adult haemophilia treatment centre South Australia	Yu-hsuan LIN	Received

PO-128	Experiences in dentistry surgeries of greater complexity in patients with hemophilia A and B in province of Salta, Argentina	maria sol cruz	Received

PP-128	Effectiveness of starting emicizumab in routine clinical practice for patients with severe hemophilia A without FVIII inhibitor: results using PicnicHealth data in the US	Letizia Polito	Received

PO-129	Clinical Outcomes of Total Knee Arthroplasty in patients with Hemophilic Arthropathy a prospective study	Hugo Saint-Yves	Received

PP-129	DIffusion of prophylaxis and introduction of innovative products in haemophilia: data from the Emilia-Romagna Regional Registry, 2003-2022	Gianna Franca Rivolta	Received

PO-130	LADIES: Bleeding Disorders in Women - Health Care and Support	Mariana Battazza	Received

PP-130	Nonacog Beta Pegol in Adolescents and Adults with Hemophilia B: Insights from an Experience in Tertiary Care Centre in Maharashtra	Varun Bafna	Received

PP-131	Sixteen years real life experience of with low dose prophylaxis in a hemophilia treatment center	Ons Ghali	Received

PP-132	First year of emicizumab prophylaxis: Preliminary results of the Brazilian Registry of Emicizumab (EMCase Study)	José Sávio Santos Ferreira Filho	Received

PP-133	Effectiveness and safety of every-5-days damoctocog alfa pegol prophylaxis in haemophilia A in phase 3, phase 4 and real-world studies	Darwin Health Communications	Received

PO-134	Correlation between age at diagnosis with clinical and joint health outcomes in patients with severe and moderate haemophilia at Kenyatta National Hospital	Anastasia Khasiani	Received

PP-134	Bleeding episodes and surgical procedures in children and adults with haemophilia A on prophylaxis with emicizumab - the experience of a Portuguese Centre.	Catarina Camara	Received

PO-135	A CASE SERIES OF THE FIRST UNDER 5-YEARS OLD PATIENTS WITH SEVERE HEMOPHILIA A AFTER USING EMICIZUMAB AT THE LARGEST CHILDRENS HOSPITAL OF PANAMA	Benilda González	Received

PP-135	Pharmacokinetic study of FIX extended half-life concentrate using differents models	Olga Benítez Hidalgo	Received

PO-136	Degree of overload in primary caregivers of patients with hemophilia.Preliminary results.	Ezequiel Martínez	Received

PP-136	Transitioning from standard to extended half-life factor VIII concentrates correlating dosing strategy with subsequent pharmacokinetic study and bleeding events	Pamela Tan	Received

PP-137	Safety and Efficacy of Emicizumab in Patients with Severe Hemophilia A and Severe Clinical Phenotypes: Retrospective Data from Nigeria	Theresa Nwagha	Received

PO-138	Incidence and Prevalence Trends of Hemophilia and Complications in Armenia: A Comprehensive 13-Year Retrospective Analysis (2010-2022)	Heghine Khachatryan	Received

PP-138	Use of Emicizumab in Patients with Haemophilia A: Experience from a Treatment Centre in, Ghana West Africa	Diana Dwuma-Badu	Received

PO-139	Challenges in the diagnosis and management of rare coagulation disorders in a country in crisis.	Roula Farah	Received

PP-140	Access to Prophylaxis Therapy in Hemophilia A: Results of the CLAHT-WFH Survey for Latin-America.	Jesus Ardila Novoa	Received

PO-140	Analysis of the musculoskeletal profile of patients with hemophilia, evaluated by the physiotherapy sector, at the Belo Horizonte blood center of the Hemominas foundation	Eder Santos	Received

PP-141	Paternal function difficulties and hemophilia	Veronica Cerutti	Received

PO-142	The changing paradigm of severe haemophilia A management in East Mediterranean: A survey from haemophilia treatment centres in the region.	khadiga Yehia Elalfy	Received

PO-143	Mental Health Art Contest for Adolescents with Heavy Menstrual Bleeding a Quality Improvement Initiative	Sabrina Farina	Received

PP-143	Piloting a transition readiness programme for children with haemophilia	Sheryl Seet	Received

PP-144	Bleeding Beyond the Veins	Midhat Khalid	Received

PP-145	Inclusive summer camps for children with hemophilia: 40 years of experience in the Catalan Association of Hemophilia	Felipe Ortega	Received

PP-146	The Psychosocial Aspects of Hemophilia: A Comprehensive Study	Md Shohanur Rahman Mithun	Received

PP-149	Impact of haemophilia on family functioning	Anna-Maria Tsilia	Received

PP-150	The Hemophilia Society of Türkiye Model- Newly Diagnosed Hemophilia Family Camp	Basak Koc	Received

PP-151	Depression Screening & Education for Patients with Bleeding Disorders	Denise Lowery	Received

PP-152	Impact of the COVID-19 Pandemic on weight gain in a pediatric and adult population with bleeding disorders: A single center study	Kim Schafer	Received

PP-153	Chess Game A Strategic and Therapeutic Paradigm for School-Age Individuals Navigating Hemophilia Challenges	SAMUEL MBUNYA	Received

PP-154	Empowering Patients and Families	Richa Mohan	Received

PP-155	Glanzmann Thrombasthenia Adversely Impacts Psychosocial Outcomes: The Glanzmanns 360 mixed methods study	Kate Khair	Received

PP-156	Interim results from the Lived Experience of People with Factor VII Deficiency (FVIID 360) study	Kate Khair	Received

PP-157	Development of a Core Outcome Set for von Willebrand Disease: The coreVWD Initiative	Elizabeth Clearfield	Received

PP-158	Quality of life of children, adolescents with hemophilia A and its caregivers, facing change of treatment with emicizumab. Experience in Uruguay	Felipe Lemos	Received

PP-159	Ultrasound exam for assessment tool for joint disease within people with hemophilia	Dorra Rhim	Received

PP-160	Health-related quality of life improvements following valoctocogene roxaparvovec gene therapy in people without bleeds or target joints at baseline: a post hoc analysis from GENER8-1	Sandra Santos	Received

PP-161	Physical functioning and pain in older men with haemophilia	Suzanne OCallaghan	Received

PP-162	Summary data from first collaboration of PROBE and Drustvo Hemofilikov Slovenije an ongoing quality of life study.	Alexandra Kucher	Received

PP-163	Beyond the bleeding: examining the health and quality of life of hemophilia A patients within ASHEMADRID	Richard Paul Habis Khoury	Received

PP-164	Gene therapy with the Padua variant of a codon-optimized human factor IX gene etranacogene dezaparvovec in people with hemophilia B: effects on patient-oriented outcomes measured using the Patient Reported Outcomes, Burdens and Experiences (PROBE) questio	Meghan Booth	Received

PP-165	PROBE: Brazil data	Tania Maria Onzi Pietrobelli	Received

PP-166	QOL improvement project for adult hemophilia patients using smart watch	Seung Geun Kim	Received

PP-167	National Member Organizations PROBE Data Dashboard Update Adding A Pain Dashboard Page for Better Understanding of the Pain Impact in People with Hemophilia.	Alexandra Kucher	Received

PP-168	An innovative approach to helping people living with rare bleeding disorder (RBD) to initiate and retounr to behaviours that promote joint health.	thomas sannié	Received

PP-169	Quality of life (QoL) of people with hemophilia (PwH) in Madagascar	Stephania Niry Manantsoa	Received

PP-171	Characteristics of the health-related quality of life in patients with severe hemophilia A treated with Emicizumab at the National Institute of Hematology and Blood Transfusion (NIHBT) in 2021	Mai Nguyen	Received

PP-172	The quality of life among hemophilia patients in South Kalimantan, Indonesia	Wulandewi Marhaeni	Received

PP-173	Perioperative Management of a Series of Patients with Hereditary Factor X Deficiency	Diana Patiño-Culma	Received

PP-174	Cardiovascular risk factors profile in adult patients with Haemophilia in Morocco	Mouad Lamtai	Received

PP-175	Acquired hemophilia A in Portugal in the last 18 years the experience of the 5 Haemophilia Centres	Cristina Catarino	Received

PP-176	Intracranial hemorrhage in children with hemophilia : a 7-years retrospective study in a single-center in Indonesia	Novie Amelia Chozie	Received

PP-177	Impact of the G403T mutation in coagulation factor XI deficiency: insights from a southern Tunisia patient cohort.	Mohamed Elloumi	Received

PP-178	Enhancing Hemostasis in Severe Hemophiliacs with Rheumatic Heart Disease: A Pilot Study on Comprehensive Surgical Management	Shruti Mishra	Received

PP-179	Lower doses of bypass agents achieve satisfactory haemostasis during major surgery in patients with haemophilia and inhibitors	Aby Abraham	Received

PP-180	VWDtest.com continues promoting global awareness of von Willebrand disease	Fernando Corrales-Medina	Received

PP-181	Spectrum of bleeding manifestations in patients with type 3 von Willebrand disease	Dinesh Chandra	Received

PP-182	Assessment of ISTH-BAT score in von Willebrand disease patients	Agoritsa Varaklioti	Received

PP-183	Assessing the hemostatic effect of factor replacement therapies under blood flow conditions in Von Willebrand disease	Elena G Arias-Salgado	Received

PP-184	Validation of a Rapid Diagnostic Approach in Inherited and Acquired defects of VWF by Automatic Tests assessed before and after DDAVP trial: Results from the Chinese-Italian CREWILACT Study	Augusto B Federici	Received

PP-186	Significance of joint ultrasound examination in a medical check-up for hemophilic carriers	Teruhisa Fujii	Received

PP-187	Creating a multidisciplinary supporting group for female hemophilia carriers	Patricia Cabré	Received

PP-188	Abnormal haemostasis and bleeding problems seen in possible carriers of haemophilia A: a pilot study	Taiwo Kotila	Received

PP-189	Characterization of hemostasis disorders in patients with menorrhagia	Dunia Castillo González	Received

PP-190	Changing perspectives about women in bleedings disorders community, role and participation	amanda brito del pino	Received

PP-191	The accurate classification of women with hemophilia and the importance of genetic studies.	Liliana Rossetti	Received

PP-192	Reasons for consultation among women and girls with bleeding disorders in Venezuela: review of the last two years	Apsara Boadas de Sánchez	Received

PP-194	Semiological assessment and use of scales in patients with excessive menstrual bleeding in primary care: a pending task.	BOLIVAR LUIS DIAZ JORDAN	Received

PP-195	Women diagnosed with postpartum hemophilia, more than an anecdotal fact: Retrospective analysis in a single center	BOLIVAR LUIS DIAZ JORDAN	Received

PP-196	Once upon a time UNSEEN LIFE: Stories of Women Carriers of Hemophilia in Latin America	Maria Belén Robert	Received

PP-197	Update on the diagnosis of haemophilia carrier women: experience from a centre	Daniela Neme	Received

PP-198	Trauma and Taboo. Family story of women with bleeding disorder in Poland.	Bernadetta Pieczynska	Received

PP-199	Commission of Women with Coagulopathies of the Spanish Federation of Hemophilia (Fedhemo)	Laura Quintas	Received

PP-200	Findings from the WFH NMO survey on women and girls with bleeding disorders	Salome Mekhuzla	Received

PP-205	Health Education Needs in Hematological Orphan Diseases for Sick People and Caregivers in Ibagué, Tolima, Colombia	NADIA ESPERANZA PERDOMO OLARTE	Received

PP-212	Women with low rate hemophilia A carrier or severe von Willebrand disease: how facing up in low-income countries?	Laurent Frenzel	Received

WFH 2024 World Congress

21 - 24 April 2024, Madrid

About us

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 21/04/2024 TO 21/04/2025

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions

Special Access

Commercial Web Access